LB

Lalit Bhatt

Active Director Director DIN 11684068
DIN 11684068 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Lalit Bhatt

Data last updated:

Lalit Bhatt is a Director at Mediquest Life Sciences Private Limited (since 2026) and Director at Rogaro Pharma Private Limited (since 2026).

DIN 11684068
Primary Designation Director
First Appointment 24 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Oct 20262026Active
Rogaro Pharma Private Limited U46497HR2026PTC144652
Director24 Apr 20262026Active

Board colleagues of Lalit Bhatt

Directorship timeline

Open interactive timeline →
Rogaro Pharma Private Limited
Mediquest Life Sciences Private Limited
Premium access

Shareholding and investment profile for Lalit Bhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalit Bhatt

Lalit Bhatt currently holds 2 directorships: Mediquest Life Sciences Private Limited (Director, since 15 Oct 2026); Rogaro Pharma Private Limited (Director, since 24 Apr 2026).

Lalit Bhatt was first appointed on 24 Apr 2026 as Director at Rogaro Pharma Private Limited.

The current boards of Lalit Bhatt's companies include Akash Deep (Mediquest Life Sciences Private Limited), Anurag Singh (Mediquest Life Sciences Private Limited), Ruby (Rogaro Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available